EMA Authorised: Desloratadine Teva (desloratadine) — Teva B.V

View source ↗

Summary

Desloratadine Teva has been authorised by the EMA for allergic rhinitis (perennial and seasonal).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Allergic Rhinitis

Drugs mentioned

• Desloratadine Teva (desloratadine)

Snippet

Status: Authorised. Therapeutic area: Rhinitis, Allergic, Perennial;Rhinitis, Allergic, Seasonal. MAH: Teva B.V. Decision date: 14/07/2026